aluminum hydroxide 6.33 MG/ML / magnesium carbonate 23.9 MG/ML Oral Suspension [Gaviscon]
RxNorm concept 1251365, branded drug (sbd). Prescribable name: Gaviscon Regular Strength 95 MG / 358 MG in 15 mL Oral Suspension.
- RxCUI
- 1251365
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1251365 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Gaviscon (aluminum hydroxide 31.7 MG / magnesium carbonate 119.3 MG) per 5 ML Oral Suspension; Gaviscon (aluminum hydroxide 95 MG / magnesium carbonate 358 MG) per 15 ML Oral Suspension
Related concepts
- aluminum hydroxide 6.33 MG/ML (SCDC, consists of)
- magnesium carbonate 23.9 MG/ML (SCDC, consists of)
- aluminum hydroxide 6.33 MG/ML / magnesium carbonate 23.9 MG/ML [Gaviscon] (SBDC, consists of)
- Oral Suspension (DF, has dose form)
- Gaviscon (BN, has ingredient)
- aluminum hydroxide 6.33 MG/ML / magnesium carbonate 23.9 MG/ML Oral Suspension (SCD, tradename of)
Linked data
NDCs
- 00088117112
- 00088117114
- 00135009441
- 00135009442
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 1251365 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1251365 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1251365. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.